{
	"id": "CVE-2017-17678",
	"vulnerabilities": [
		{
			"content": {
				"id": "CVE-2017-17678",
				"description": "BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.",
				"references": [
					{
						"source": "CVE",
						"url": "http://bmc.com"
					},
					{
						"source": "CVE",
						"url": "http://remedy.com"
					},
					{
						"source": "CVE",
						"url": "https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html"
					},
					{
						"source": "CVE",
						"url": "https://seclists.org/fulldisclosure/2017/Oct/52"
					},
					{
						"source": "mitre",
						"url": "http://bmc.com"
					},
					{
						"source": "mitre",
						"url": "http://remedy.com"
					},
					{
						"source": "mitre",
						"url": "https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html"
					},
					{
						"source": "mitre",
						"url": "https://seclists.org/fulldisclosure/2017/Oct/52"
					}
				],
				"modified": "2024-08-05T20:59:17.571Z"
			}
		}
	],
	"data_source": {
		"id": "mitre-v5",
		"raws": [
			"vuls-data-raw-mitre-v5/2017/CVE-2017-17678.json"
		]
	}
}
